Association between concomitant psychiatric drug use,and patients’ beliefs about and persistence with chronic cardiovascular medication
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023884%3A_____%2F12%3A00006050" target="_blank" >RIV/00023884:_____/12:00006050 - isvavai.cz</a>
Výsledek na webu
<a href="http://dx.doi.org/10.1111/ijcp.12544" target="_blank" >http://dx.doi.org/10.1111/ijcp.12544</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/ijcp.12544" target="_blank" >10.1111/ijcp.12544</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Association between concomitant psychiatric drug use,and patients’ beliefs about and persistence with chronic cardiovascular medication
Popis výsledku v původním jazyce
Objective: Psychiatric disorders are associated with an increased risk of cardiovascular diseases and may result in additional risk of non-adherence. No data on the influence of concomitant psychiatric drug use on patients’ beliefs and persistence related to cardiovascular medication are available. The objective of this study was to assess to what extent the use of concomitant psychiatric drugs is associated with patients’ beliefs about and persistence with chronic cardiovascular medication. Methods: An observational study in patients using cardiovascular medication was conducted. A mailed questionnaire containing socio-demographical questions and a measure of beliefs about medication (Beliefs about Medicines Questionnaire – specific) was sent to patients selected from fifteen participating pharmacies. Persistence was evaluated based on pharmacy records. Results: Of the 1547 included patients, 551 responded to key questions in the questionnaire and were included for beliefs about medication analysis. In concomitant users of psychiatric drugs significantly higher necessity (17.0 vs. 16.0) and higher concerns (14.3 vs. 13.3), as well as higher proportion of ambivalent (34.5% vs. 25.6%) and lower proportion of indifferent patients (24.1% vs. 33.0%) were found compared with non-users (p < 0.05). 65.2% (n = 1009) of patients were persistent on all their cardiovascular drugs. There was no significant association between concomitant use of psychiatric drugs and non-persistence (OR = 1.2; 95% CI 0.9–1.5). Conclusion: Concomitant use of psychiatric drugs was found to be associated with increased beliefs about the necessity of and concerns about cardiovascular medication. Clinicians caring for cardiovascular patients should give additional attention to identifying patients’ beliefs about medication among those concomitantly using psychiatric drugs.
Název v anglickém jazyce
Association between concomitant psychiatric drug use,and patients’ beliefs about and persistence with chronic cardiovascular medication
Popis výsledku anglicky
Objective: Psychiatric disorders are associated with an increased risk of cardiovascular diseases and may result in additional risk of non-adherence. No data on the influence of concomitant psychiatric drug use on patients’ beliefs and persistence related to cardiovascular medication are available. The objective of this study was to assess to what extent the use of concomitant psychiatric drugs is associated with patients’ beliefs about and persistence with chronic cardiovascular medication. Methods: An observational study in patients using cardiovascular medication was conducted. A mailed questionnaire containing socio-demographical questions and a measure of beliefs about medication (Beliefs about Medicines Questionnaire – specific) was sent to patients selected from fifteen participating pharmacies. Persistence was evaluated based on pharmacy records. Results: Of the 1547 included patients, 551 responded to key questions in the questionnaire and were included for beliefs about medication analysis. In concomitant users of psychiatric drugs significantly higher necessity (17.0 vs. 16.0) and higher concerns (14.3 vs. 13.3), as well as higher proportion of ambivalent (34.5% vs. 25.6%) and lower proportion of indifferent patients (24.1% vs. 33.0%) were found compared with non-users (p < 0.05). 65.2% (n = 1009) of patients were persistent on all their cardiovascular drugs. There was no significant association between concomitant use of psychiatric drugs and non-persistence (OR = 1.2; 95% CI 0.9–1.5). Conclusion: Concomitant use of psychiatric drugs was found to be associated with increased beliefs about the necessity of and concerns about cardiovascular medication. Clinicians caring for cardiovascular patients should give additional attention to identifying patients’ beliefs about medication among those concomitantly using psychiatric drugs.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30104 - Pharmacology and pharmacy
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2015
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
International Journal of Clinical Practice
ISSN
1742-1241
e-ISSN
—
Svazek periodika
69
Číslo periodika v rámci svazku
3
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
8
Strana od-do
328-335
Kód UT WoS článku
000350307200010
EID výsledku v databázi Scopus
2-s2.0-84988241338